(Incorporated in the Cayman Islands)

Note: This SPAC is offering only stock. This is NOT a unit offering. A typical SPAC IPO is a unit offering that usually includes a warrant or a right with a share of stock in each unit.

We are a newly organized blank check company concentrating on healthcare in Asia. We intend to focus on the life sciences and MedTech (medical technology) sectors in Asia.

Our CEO, Chen Yu, is the founder and managing member of TCG Crossover (TCGX).

Our CFO, Craig Skaling, is the CFO and COO of TCGX.

(Note: TCGX Acquisition Corp. priced its SPAC IPO in sync with the terms in the prospectus – 7.5 million shares at $10.00 per share – to raise $75 million on Tuesday night, Aug. 4, 2026.Unlike most SPAC IPOs, TCGX Acquisition’s deal consists only of stock – it does not include warrants or rights. Background: TCGX Acquisition filed its S-1 for its stock-only IPO on July 20, 2026, and disclosed the terms: 7.5 million shares at $10.00 each to raise $75.0 million.)